Verisk Analytics (VRSK) is back in focus after reporting Q2 2026 adjusted EPS and revenue that surpassed analyst forecasts, helped by subscription revenue and other business lines that supported the latest financial results.

At a latest share price of US$187.50, Verisk Analytics has seen its 90 day share price return rise 9.58%, although the year to date share price return is down 15.17% and the 1 year total shareholder return has declined 30.20%. This suggests recent momentum is improving from a weaker longer term picture as investors digest the Q2 beat and reassess the risk and growth profile.

If the Q2 surprise has you reviewing your watchlist, this can be a useful time to scan beyond Verisk and look at other ideas through the 21 top founder-led companies

Verisk Analytics now trades at a clear discount to both analyst targets and some intrinsic value estimates after a sharp share price reset. Is that a genuine mispricing, or a fair reflection of market caution around the story?

Most Popular Narrative: 144% Overvalued

Verisk Analytics last closed at $187.50, while the most followed narrative on the stock, according to Esteban, anchors on a fair value of $76.85. That gap frames a very different story from the recent Q2 share price rebound.

Verisk Analytics is a regulatory-grade data toll on the US property & casualty insurance industry, monetized through approximately 83% subscription revenue with approximately 92% client retention. VRSK's narrow-moat franchise produces FCF with an unusually high degree of predictability, durable enough to justify a 15× exit multiple at a 35% margin of safety.

Want to see how a slow revenue base can still support a punchy valuation? The narrative leans on margin strength, subscription stickiness, and a premium exit multiple. Curious what assumptions connect those dots for Verisk Analytics.

Result: Fair Value of $76.85 (OVERVALUED)

However, Verisk Analytics still faces risks if revenue growth slows further or client retention weakens, which could challenge assumptions behind its premium multiple and cash flow profile.

Another View on Verisk Analytics: DCF vs Narrative

Esteban’s narrative points to Verisk Analytics being heavily overvalued, with a fair value of $76.85. Our DCF model points in the opposite direction. It estimates a fair value of $231.91, which is 19.2% above the current share price of $187.50 and suggests undervaluation. Which set of assumptions do you find more believable?

For a closer look at how this cash flow based view is built, and how sensitive it might be to changing inputs, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Verisk Analytics for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The split views on Verisk Analytics in this article highlight both concern and optimism around its outlook, so it makes sense to weigh the signals yourself and do it promptly. To see the balance of potential downsides and upsides that other investors are watching, take a close look at the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Verisk Analytics?

If Verisk Analytics has you rethinking your portfolio, now is a smart moment to widen your search and line up a few fresh ideas before the next move.

• Target reliable cash generators by scanning companies that appear in the 48 high quality undervalued stocks.
• Strengthen portfolio resilience by focusing on businesses highlighted in the 78 resilient stocks with low risk scores.
• Add potential future standouts by reviewing the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.